Loading insider details...
Latest Form 4 (Mar 7, 2026): Grant/Award of 1,050,000 LCTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 7, 2026 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 1,050,000 | n/a |
| Mar 12, 2025 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 750,000 | n/a |
| Nov 26, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Purchase | 15,000 | $8.8K |
| Aug 19, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Purchase | 10,500 | $9.3K |
| Jun 6, 2024 | BIORA THERAPEUTICS, INC. (BIOR) | Grant/Award | 12,500 | n/a |
| Mar 8, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 650,000 | n/a |
| Mar 11, 2023 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 150,000 | n/a |
| Nov 16, 2022 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 1,000,000 | n/a |